GITR

GITR 詳細

英語名Glucocorticoid-induced tumor necrosis factor receptor-related protein市販薬剤の数0
治験薬の数4ターゲットの別称TNFRSF18,TNF Receptor Superfamily Activation-Inducible Protein,ENERGEN,GITR-D,Tumor Necrosis Factor Receptor Superfamily Member 18,CD357 Antigen,Activation-Inducible TNFR Family Receptor,AITR,CD357,GITR,Glucocorticoid-Induced TNFR-Related Protein,Tumor Necrosis Factor Receptor Superfamily, Member 18,TNF Receptor Superfamily Member 18
研究&開発段階Phase 2 Clinical
英語名Glucocorticoid-induced tumor necrosis factor receptor-related protein
ターゲットの別称TNFRSF18,TNF Receptor Superfamily Activation-Inducible Protein,ENERGEN,GITR-D,Tumor Necrosis Factor Receptor Superfamily Member 18,CD357 Antigen,Activation-Inducible TNFR Family Receptor,AITR,CD357,GITR,Glucocorticoid-Induced TNFR-Related Protein,Tumor Necrosis Factor Receptor Superfamily, Member 18,TNF Receptor Superfamily Member 18
市販薬剤の数0
治験薬の数4
研究&開発段階Phase 2 Clinical

GITR 製品リスト

  • 属性

    Protein (7)

  • 製品ライブラリ

    オンライン (7)

  • Human (4)Canine (1)Mouse (2)

  • タグ

    His Tag (3)Fc Tag (1)Fc Tag & Avi Tag (1)His Tag & Avi Tag (2)

  • マーカー

    Unconjugated (4)Biotin-labeled (3)

GITRバックグランド

Glucocorticoid-induced TNFR-related protein (GITR) is also known as Tumor necrosis factor receptor superfamily member 18 (TNFRSF18), activation-inducible TNFR family receptor (AITR), CD antigen CD357, which is a member of the tumor necrosis factor receptor (TNF-R) superfamily. GITR is receptor for TNFSF18, which seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. GITR also mediated NF-kappa-B activation via the TRAF2/NIK pathway.

GITR分子の別称

AITR,GITR,TNFRSF18,CD357

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
BMS-986156BMS-986156Phase 2 ClinicalBristol-Myers Squibb CompanyLiver Neoplasms; Lung Neoplasms; Neoplasms; Solid tumours; Thoracic Neoplasms
詳細
RagifilimabINCAGN-1876; INCAGN-01876; AGEN-1876; CM-701Phase 2 ClinicalAgenus Inc, Ludwig Institute For Cancer ResearchNeoplasm Metastasis; Neoplasms
詳細
Anti-GITR antibody (BMS)Phase 1 ClinicalBristol-Myers Squibb CompanyNeoplasms
詳細
IBI-102IBI102; IBI-102Phase 1 ClinicalNeoplasms
詳細

レビュー

  • 1***32019-09-27
    1評価
    I have been using Acro's products for a long time. Whenever there is some concerns on product or technical support is needed, it always gets solved in time. I used the GITR protein for SPR experiments. I have done 6 concentration gradients, and the fitted curve was still very good. The data also met my expectations. I hope we will continue having a good cooperation with ACRO moving forward.
  • 詳細
  • 製品リスト
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8